KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Prepaid Assets (2016 - 2025)

Acadia Pharmaceuticals (ACAD) has 16 years of Prepaid Assets data on record, last reported at $59.5 million in Q4 2025.

  • For Q4 2025, Prepaid Assets rose 6.91% year-over-year to $59.5 million; the TTM value through Dec 2025 reached $59.5 million, up 6.91%, while the annual FY2025 figure was $59.5 million, 6.91% up from the prior year.
  • Prepaid Assets reached $59.5 million in Q4 2025 per ACAD's latest filing, down from $60.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $60.9 million in Q3 2025 and bottomed at $21.0 million in Q2 2022.
  • Average Prepaid Assets over 5 years is $37.0 million, with a median of $33.2 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: dropped 20.05% in 2022, then soared 92.74% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $23.9 million in 2021, then fell by 10.44% to $21.4 million in 2022, then surged by 82.69% to $39.1 million in 2023, then skyrocketed by 42.44% to $55.7 million in 2024, then increased by 6.91% to $59.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $59.5 million in Q4 2025, $60.9 million in Q3 2025, and $52.7 million in Q2 2025.